The U.K.'s Office of Fair Trading is proceeding with its action against GlaxoSmithKline, alleging it held back generic competition to its best-selling antidepressant paroxetine from 2001 to 2004 through agreements with generic drug firms.

Brief summaries of recent product and company developments in the device industry, including: developments in continuous glucose monitoring, new liability conerns for device companies, medtech acquisitions in 2007, and the 2008 IPO market.

Noteworty news from medtech start-ups. In this issue: NOTES companies promise the least invasive surgery, with brief profiles of Apollo Endosurgery, Minos Medical and Cardiorobotics. (Adapted from "NOTES Companies Sing an Upbeat Tune," START-UP, December 2007.)

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.